chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was given the vaccine in the right upper arm.  I picked that arm due to PHN in my left trigininal nerve from shingles. They gave me the vaccine and I proceeded to move my car to the 30 minute waiting area. I put the car in park and suddenly I felt dizzy. Like I was looking through a magnifying glass backwards. Since I have a reaction to Xolair in 12/15/2021 I had been extra cautious. This hit my quickly. It felt like I had a ton of weight on my chest. It progressed quickly to where I felt like I couldn't breath. The staff was watchful. They called an ambulance.  They monitored me there but it was like I could not wake up. I wanted to fall asleep. My blood pressure was higher than normal at one point during my ER visit I looked up and my blood pressure was 137/91. I felt like I had when I had a many stroke in 2019 my speech was slower I couldn't get the words out. My toes and finger were cold. They transported me to the ER for observation. It was that that the head ache only in my right frontal lobe started and my arm and neck on the right side began to hurt. Within about 1.5 hours I began to wake up from the fog and my speak cleared up. While laying on the bed my fingers were curling up. As the speech returned that hands warmed up.and my fingers began to release. The staff at the clinic had given me benadryl within about 20 minutes of the vaccine.  Upon release I was droggy and like a huge adrenal rush had worn off. I had slight stuffy nose and like I had a severe hay fever reaction that I was coming down from last night. This hit me quick and hard. The ER said I had a stress reaction and a head ache of unknown cause as all of my blood work came back normal. But honestly at one point I felt paralyzed. Even today I feel stuffier than I normally do. Like I have a slight asthma attack.  I know my blood oxygen was 97 % at one point and I can tell when it drops even a precent
5 minutes, post vax, pt's right arm became reddened with hives in muscle approximately 1 1/2cm in size. Ice was applied and after about 10 minutes hives were gone with only slight redness.
Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "Reason for Admission: Ground level fall  82 YO female with h/o subarachnoid hemorrhage 2/2 to intracranial aneurysm, Antithrombin 3 deficiency, CKD3, HTN, OA, HLD, T2DM who is presenting to the ED for evaluation of generalized weakness   Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  treated for COVID pneumonia, superadded bacterial pneumonia, congestive heart failure transferred to care tel when off COVID isolation Acute hypoxic respiratory failure-resolved, required high-flow nasal cannula oxygen, on admission, in the setting of COVID positive, partially vaccinated On dexamethasone"
Dizziness, nausea, always feeling like he is falling down. He stated he has to urine alot and his heart pounding and beating abnormally fast. Stabbing pain in his hands.
Woke up in the middle of the night with intense abdominal cramping, which felt like intense menstrual cramps. Stomach became distended and very tender. Continued for several days and I can still feel tenderness and swelling around uterus, as well as pain in ovaries.
I started feeling really thirsty and was drinking tons of water, and soon came to realize that water didn't make a difference and that I dry mouth.  I've never had this in my life.  I don't have diabetes or anything I can find online that would cause it.  I'm very concerned that this isn't going to go away, because I'm at 9 days, and it's still a big problem.
Headaches, chills, vomiting and generalized aching all over. This lasted 2-3 weeks
Having shortness of breath, lots of fatigue.  Received Regeneron on 08/09/2021
vaccine had been out of the fridge for 18 hours; vaccine had been out of the fridge for 18 hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine had been out of the fridge for 18 hours) and PRODUCT STORAGE ERROR (vaccine had been out of the fridge for 18 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine had been out of the fridge for 18 hours) and PRODUCT STORAGE ERROR (vaccine had been out of the fridge for 18 hours). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (vaccine had been out of the fridge for 18 hours) and PRODUCT STORAGE ERROR (vaccine had been out of the fridge for 18 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  It was reported that the Moderna COVID-19 Vaccine was left at room temperature at 02:58 PM on 14Jun2021 and then administered to three individuals on 15un2021. No patient information was provided other than this was the first dose for two patients and the second dose for one patient.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up received and contains no new information
Admit date: 9/11/2021   Date of Death and Time: 09/13/21 at 12:05   Admitting Physician:     Physician:    Admission Diagnoses: Hyperkalemia [E87.5] Lactic acidosis [E87.2] Hypotension [I95.9] SIRS (systemic inflammatory response syndrome) (CMS/HCC) [R65.10] AKI (acute kidney injury) (CMS/HCC) [N17.9] Septic shock (CMS/HCC) [A41.9, R65.21] Left lower quadrant abdominal pain [R10.32]   Diagnoses at Time of Death:  Septic shock Acute kidney injury on CKD SARS-CoV-2 infection Acute hypoxemic respiratory failure History of atrial fibrillation History of hypertension Morbid obesity Diabetes mellitus History of hypothyroidism   Admission Condition: critical   Indication for Admission:    Hospital Course:  Patient was admitted with abdominal and back pain, cough and hypoxia. Documented to be hypotensive at the emergency department with evidence of worsening creatinine and hyperkalemia. CT imaging demonstrated peripancreatic, duodenal stranding with mild rectal wall thickening and vascular calcifications. Patient required vasopressors through central venous catheter as well as broad-spectrum antibiotics. She was known to have chronic kidney disease with new acute kidney injury, was treated with bicarbonate, calcium gluconate. Patient had worsening of her respiratory status and required bilevel positive airway pressure.  She changed her CODE STATUS to DO NOT RESUSCITATE after admission. Was seen by nephrology with a recommendation for continued dialysis, started after placement of temporary dialysis catheter.  Patient had worsening mental status becoming minimally responsive. Had progressive deterioration with increasing requirements for hemodynamic support, at some point on maximal dose of norepinephrine and phenylephrine. Testing was positive for SARS-CoV-2 for which she was treated with dexamethasone She continued to have deterioration of her overall status, hypothermic, acidemic, with severely elevated creatinine, anuria, dependent on noninvasive ventilatory support.  This was discussed with her POA who mentioned that patient would not want to depend on artificial life-sustaining measures. A decision was made to change focus of care to comfort and aggressive management was discontinued   Patient was pronounced deceased on September 13, 2021 at 12:05 PM   Consults:  Critical Care Nephrology    Pulmonary and Critical Care Medicine
Slight cellulitis at the injection site; Sore arm; Fever of about 102.4°; Nausea; A spontaneous report was received from a consumer who is a 79-year-old female patient that received Moderna's COVID-19 vaccine (mRNA-1273) vaccine and experienced cellulitis at injection site/injection site cellulitis, sore arm/pain in extremity, fever to 102.4/pyrexia, nausea.  The patient's medical history was not reported. Products known to have been used by the patient, within two weeks prior to the event were not reported.  On 05-FEB-2021, prior to the onset of events, the patient received the first dose of two planned doses of mRNA-1273 (Batch number:011M20A) intramuscularly on arm for prophylaxis of COVID-19 infection.   On an unknown date, after receiving the first dose of vaccine, patient experienced feeling a sore arm, like a slight cellulitis at injection site, fever of 102.4 and nausea. The event injection site cellulitis was considered as serious (Medically Significant).  Treatment medication included alcohol which was used at the injection site. Laboratory tests were not reported.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the events experienced cellulitis at injection site/injection site cellulitis, sore arm/pain in extremity, fever to 102.4/pyrexia and nausea were considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
After receiving Iz patient stood became weak, pale diaphoretic (BP normal) stated she was very dizzy.  Patient placed on bed until dizziness subsided.
Treatment failure of prescribed medication possibly related to Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of TREATMENT FAILURE (Treatment failure of prescribed medication possibly related to Moderna vaccine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylaxis.    Co-suspect product included non-company product COBICISTAT, ELVITEGRAVIR, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (GENVOYA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and COBICISTAT, ELVITEGRAVIR, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (GENVOYA) (unknown route) at an unspecified dose. In June 2021, the patient experienced TREATMENT FAILURE (Treatment failure of prescribed medication possibly related to Moderna vaccine) (seriousness criterion medically significant). At the time of the report, TREATMENT FAILURE (Treatment failure of prescribed medication possibly related to Moderna vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, Laboratory test: abnormal (abnormal) Spike in my levels.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  It was reported that the patient's physician switched his medication because it was failing (Genvoya)  This case concerns 61-year-old, female patient with no relevant medical. The patient experienced serious events of Treatment failure unspecified days after the third dose of spikevax. The reporter didn't provide the causality of events. Rechallenge is not applicable  as the event reported to have occurred after the 3rd dose.  The benefit-risk relationship of Spikevax is not affected by this report.; Sender's Comments: This case concerns 61-year-old, female patient with no relevant medical. The patient experienced serious events of Treatment failure unspecified days after the third dose of spikevax. The reporter didn't provide the causality of events. Rechallenge is not applicable  as the event reported to have occurred after the 3rd dose.  The benefit-risk relationship of Spikevax is not affected by this report.
Following Pneumovax immunization in left deltoid, raised area 2 1/2 X 3 over left bicep developed, red, warm to touch. Patient self-treated with Benadryl PO presented on 11-17-06 for observation. Referred to PCP who diagnosed cellulitis and treated with IM Rocephin and oral Ceftin.
Patient woke up with a temperature of 101.2 and her left arm was swollen about twice the size as normal. She could not get her sleeves of her shirts on it.
Swelling & pain in arm & down to hand. Noticed the next morning after getting the shot.
On day 9 post vaccine my injection site became hard, began to itch, ache ,swell and is hot to touch.  Issue is ongoing as this is reported. Taking Benadryl and applying cortisone to the area.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vials were used to provide 38 doses) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant and treatment medications were reported by reporter.Most recent FOLLOW-UP information incorporated above includes:On 19-Nov-2021: Follow Up received on 19-Nov-2021 (Second reporter Information is updated.)
3/19-girlfriend calling for 81 yo boyfriend who is having the reaction. she does not have much specific info but wanted for us to follow this afternoon. rec po fluids, rest and antipyretics prn. 3/22-Follow up call by Patient feeling much better  since 3/21/21. Has taken Tylenol to alleviate symptoms. No signs and symptoms at this time.
approx 6 hrs p/vax pt noted to have sz type episode; unresponsive, face drawn to rt side, tonic posturing, cyanotis, eyes rolling from extreme rt-lt cessation of breathing episode approx 2 minutes duration;
Make that joint pain worse; Did not sleep well last night; Nausea; Feels a little bit tired, described as draggy; Specifically joint pain in her Sacral Iliac joint that she has had before just flared up; Diarrhea; Nervous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 80 year-old female patient received bnt162b2 (COMIRNATY), administration date 25Oct2021 (Batch/Lot number: unknown) at the age of 80  as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Colitis" (unspecified if ongoing); "Joint pain" (unspecified if ongoing), notes: she started with joint pain, has joint pain anyway. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 Immunization; Bnt162b2 (Dose: 2), for COVID-19 Immunization. The following information was reported: ARTHRALGIA (non-serious) with onset Oct2021, outcome "unknown", described as "Specifically joint pain in her Sacral Iliac joint that she has had before just flared up"; DIARRHOEA (non-serious) with onset Oct2021, outcome "unknown", described as "Diarrhea"; NERVOUSNESS (non-serious) with onset Oct2021, outcome "unknown", described as "Nervous"; CONDITION AGGRAVATED (non-serious) with onset 27Oct2021, outcome "unknown", described as "Make that joint pain worse"; NAUSEA (non-serious) with onset Oct2021, outcome "unknown", described as "Nausea"; FATIGUE (non-serious) with onset Oct2021, outcome "unknown", described as "Feels a little bit tired, described as draggy"; INSOMNIA (non-serious) with onset 26Oct2021, outcome "unknown", described as "Did not sleep well last night". Therapeutic measures were taken as a result of arthralgia.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
8/26/21: pt presents to ED with weakness for 7 days and tests COVID pos 8/28/2021: discharged on zinc mild case
Chills, vomiting, diarrhea, extreme muscle soreness in right arm, tingling throughout right arm
The patient was given a Gardasil-9 shot instead of the Tdap shot.
Pt c/o constant migraines 2-3 days after receiving his 1st dose of Anthrax. Pain is dull across the eyes and temples/top of scalp. Daily occurrence.
intussusception; INTESTINAL OBSTRUCTION; Information has been downloaded from regulatory authority (US-EMA-20110128-rtevhumanwt-144948554).  This spontaneous report was received from a physician concerning a 6-month-old patient with gastro-esophageal reflux and pyloric stenosis.      On 23-MAR-1999, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II)lot# 15382, (dose, route, the expiration date and frequency were not provided) for prophylaxis.  Other suspect therapies included hib polysaccharide vaccine (manufacturer unknown)injection, lot# 423203A (dose, route, frequency and the expiration date were not reported) diphtheria toxoid, pertussis acellular 3-component vaccine, tetanus toxoid (INFANRIX)injection, lot# 90382  (dose, route and the expiration date were not provided), poliovirus vaccine live oral (ORIMUNE) orally, lot# 459-352 (dose, frequency and the expiration date were not reported) and rotavirus vaccine (unspecified) (manufacturer unknown)orally, batch/lot # unknown (dose, frequency, lot# and the expiration date were not reported). All the vaccines were received for prophylaxis. On 13-APR-1999, the patient was vaccinated with a dose of rotavirus vaccine (unspecified) (manufacturer unknown) one dosage form (1 doses) as immunisation.   On 17-APR-1999, the patient experienced intestinal obstruction and on an unknown date, the patient experienced intussusception.      The outcome of intestinal obstruction was reported as recovered (unspecified date). The outcome of intussusception was unknown.  The relatedness between the suspect vaccines and intestinal obstruction and intussusception was not reported.  The intestinal obstruction and intussusception  were considered to be medically significant by the physician.  Lot number 15382 is an invalid lot number for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live.; Sender Comments:Fax-ref: F2057F1
nausea, stomach ache,  pale skin, lost her vision for a couple of minutes, dizziness, weakness, felt like she was going to pass out
sore arm at injection site, headache, chills, muscle aches, fatigue, nausea, and fever (104 degrees) started 8 hours after shot and continued for a day By 48 hours after vaccination, most of these side effects were gone except minor headache and minor muscle aches and fatigue. Menstrual cycle also started early, 56 hours after vaccination, with more bleeding than usual and more painful menstrual cramps.
8/2/21 pt had a positive COVID test; reports sx 1 wk prior to test; admitted to hosp on 8/9 - 8/10/21 and was treated with dexamethasone and dc'd to home on RA; 8/22/21 presents to ED with worsening SOB; admitted; AKI; developed bradycardia; O2 need increased to BiPAP; given steroids and baricitinib; given IVIG infusion; pt continued to worsen and needed more O2, Vapotherm and NRB; pt's condition continued to decline; family transitioned pt to comfort measures and he passed away in the hospital
Redness and swelling on the day of administration only (locally) involved entire arm (left). Pain radiating up to mid forearm (left). Lasted few hrs, completely resolved. No previous reaction to previous doses.
Tingling feeling from top of left arm a little way to fingers - sensation is lasting 24 hours per day.
PT reports day after vaccination experiencing body aches, fever 101, chills throughout day.  improved overnight.  next day experienced fatique and mild rash at vaccination site.  rash persisted for 1 week and patient describes rash as expanding to palm size, NO itching, raised, warm and red.  tenderness and pain at injection site accompanied rash.  rash cleared after 1 week but pt reports arm was still sore and tender for days after rash cleared.
Anaphylactoid reaction based on postmortem tryptase level of 87.1 ng/ml. This postmortem level is elevated.
No additional AE; improperly stored vaccine administration; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 05-AUG-2020, the patient was vaccinated with a dose of improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot# number reported as 031812 (not valid), expiry date: 26-SEP-2020, route of administration not reported). Temperature excursion was 30.7 degree of Fahrenheit through 15 minutes and subsequently 32 degree of Fahrenheit through 45 minutes. There was no previous temperature excursion. Temperature excursion was detected by Data Logger. No adverse event reported.
2 days after: headache, body chills, sore throat, and fatigue. Third day: fatigue and body aches
Fever; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Pt received above vaccinations. Approx 5 minutes later pt watched another child receive vaccinations. Pt fell down on floor, hit nose on chair, pt was unresponsive and shaking for approx 5 seconds. Pt assisted off floor and into a chair. Pt assessed, pt responding to questions. Pt appears pale. Pt given a sucker and a glass of orange juice, which he consumed with no assistance. Pt assessed again at 5 and 10 minutes post-incident, and pt observed for 20 minutes after incident. Pt given ice for nose. Pt stated he felt normal, and left office with no assistance.
Patient noted 2" raised red bumps around site that lasted 1 hour. Stated could not lift arm overhead due to "severe pain". Pain improved by morning but states now has "severe headache". Has take Advil and will f/u with MD if not improved.
Elevated blood pressure, tingling of the tongue within a few minutes of receiving the vaccine.  Sent to ED and treated with Benadryl 25mg. Followed up at 10:15am 1/7/2021 and she is doing ok.
Pt received Menactra and Tdap in right deltoid about 10 hours later developed swollen arm to fingers with numbness, C?O wrist pain slowly improving.